Research graph
References from Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Preoperative versus postoperative chemoradiotherapy for rectal cancer
10.1056/nejmoa040694 · 2004 · External reference
Neoadjuvant treatment response as an early response indicator for patients with rectal cancer
10.1200/jco.2011.39.7901 · 2012 · External reference
Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: A meta-analysis
10.1097/dcr.0b013e318298e36b · 2013 · External reference
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
10.1016/s1470-2045(15)00120-5 · 2015 · External reference
Rectum-conserving surgery in the era of chemoradiotherapy
10.1002/bjs.7251 · 2010 · External reference
Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: Are we getting closer to anal cancer management?
10.1097/dcr.0b013e3182a25c4e · 2013 · External reference
Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy
10.1016/j.ijrobp.2012.05.017 · 2013 · External reference
Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis
10.1016/j.radonc.2014.08.035 · 2014 · External reference
Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: A dose-escalation study
10.1097/coc.0b013e31821a5844 · 2012 · External reference
Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: A randomized trial comparing two radiation doses
10.1016/j.ijrobp.2012.02.006 · 2012 · External reference
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: Boosting the dose to the shrinking tumor
10.1016/j.ijrobp.2013.05.004 · 2013 · External reference
Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients
10.3109/0284186x.2012.737022 · 2013 · External reference
High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): A phase I trial
10.3109/0284186x.2011.652740 · 2012 · External reference
Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer
10.1016/j.ijrobp.2013.02.020 · 2013 · External reference
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival
10.1016/j.ijrobp.2005.08.012 · 2006 · External reference
Randomized controlled trial for pre-operative dose-escalation BOOST in locally advanced rectal cancer (RECTAL BOOST study): Study protocol for a randomized controlled trial
10.1186/s13063-015-0586-4 · 2015 · External reference
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
10.1016/j.ijrobp.2006.05.063 · 2006 · External reference
Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: Report on late toxicity and outcome
10.1016/j.radonc.2013.10.026 · 2014 · External reference
New perspectives on predictive biomarkers of tumor response and their clinical application in preoperative chemoradiation therapy for rectal cancer
10.3349/ymj.2015.56.6.1461 · 2015 · External reference
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
10.1200/jco.2005.02.1329 · 2005 · External reference
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data
10.1016/s1470-2045(10)70172-8 · 2010 · External reference
10.1111/ans.13394
10.1111/ans.13394 · External reference
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy
10.1002/cncr.28331 · 2013 · External reference
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits
2012 · External reference
Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer
2013 · External reference
Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer
10.1016/j.ijrobp.2011.01.051 · 2012 · External reference
Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer
10.1016/j.radonc.2016.09.010 · 2016 · External reference
